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YOUNG, E. A., J. LEWIS AND H. AKIL. The preferential release of beta-endorphin from the anterior pituitary lobe by 
Cortieotropin Releasing Factor (CRF). PEPTIDES 7(4) 603-607, 1986.--Although a number of investigators have shown 
that release of ACTH is accompanied by the release of Beta-endorphin (B-End) and Beta-lipotropin (fl-LPH), the propor- 
tion of the latter two peptides released with stress or by CRF is unclear. To evaluate directly the release of B-End versus 
B-LPH from the anterior lobe, we used molecular sieving of plasma and subsequent radioimmunoassay to measure release 
of both B-End and B-LPH into plasma after thirty minutes of inescapable intermittent footshock. We found a substantial 
increase in circulating B-End which appears to be of anterior lobe origin. The B-End does not appear to represent peripheral 
conversion of B-LPH to B-End since the ratio of B-LPH:fl-End released remained constant between five and thirty minutes 
of stress, and the rate of disappearance of B-LPH is slower than the rate of disappearance of fl-End following the 
termination of stress. Further confirmation of these findings was obtained by examining the POMC derived peptides 
released by pituitary cell suspensions in the presence and absence of oCRF. While unstimulated release consisted of equal 
proportions of B-End and B-LPH, stimulation of the anterior lobe cell suspensions with oCRF resulted in the release of 
two-fold more B-End than B-LPH. 
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THE post-translational processing of  proopiomelanocortin 
(POMC) to Beta-endorphin (/3-End) and Beta-lipotropin (fl- 
LPH) differs in the anterior and intermediate lobes of rat 
pituitary. In the anterior lobe (AL), the molar ratio of/3-End 
to fl-LPH is approximately 1:2, while in the intermediate 
lobe (IL), virtually all of  the precursor is processed to/3-End 
sized or smaller material [2, 5, 12]. One might expect,  there- 
fore, that the products released during stimulation of each 
lobe would reflect these molar ratios; the anterior lobe 
should release primarily/3-LPH, while the IL would release 
/3-End 1-31 or modified forms of fl-End (e.g., alpha 
N-acetylated fl-End 1-27). Consequently, the circulating 
levels in plasma should reflect both anterior and intermediate 
lobe contributions. 
At rest, the majority of B-End immunoreactivity circulat- 
ing in rat plasma is fl-End 1-31 size [1]. The source of  this 
plasma fl-End is presumed to be intermediate lobe, since a 
sizeable proportion is alpha N-acetylated fl-End (NAc fl-End 
1-31) [1]. In contrast,  stress activates primarily the anterior 
lobe of the pituitary to release ACTH accompanied by both 
fl-LPH or fl-End [6]. Thus, if the released material truly 
reflects the molar ratios of s tored/3-LPH and/3-End in the 
anterior lobe, after stress, approximately 2/3 of the newly 
re leased/3-End like immunoreactivity in plasma should be 
/3-LPH size. 
However,  the existence of  subpopulations of releasable 
pools has been shown for POMC derived peptides in the IL 
of the frog [8]. Similarly, we have recently shown that after 
repeated phasic stress the IL releases primarily NAc fl-End 
1-31. In the IL, however,  this peptide is not the most abun- 
dantly stored [I], suggesting the existence of  specifically re- 
leasable pools. Whether such pools exist for anterior lobe 
POMC derived peptides is not known. Using mouse anterior 
lobe primary cell cultures and a double labelling technique, 
Allen et al. [3] showed that the contents of  older ACTH 
containing granules were preferentially released over newly 
synthesized material, when the culture was stimulated by 
partially purified rabbit corticotropin releasing factor. As 
expected,  these mature granules contained both fl-LPH and 
fl-End. However,  this study did not address the issue of 
differential release of fl-LPH versus fl-End. Consequently, it 
is not clear if the release of ACTH from the anterior lobe is 
accompanied primarily by the release of fl-LPH, as would be 
expected from the molar ratio, or, if significant amounts of 
fl-End can be released. Since older granules would have 
more time to continue processing, even the slowest process- 
ing reactions may have time to proceed to completion. Thus 
the preferential release of the more mature ACTH granules 
suggests that these granules could contain the most proc- 
essed form, that is, B-End. 
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To address this issue we used a dual approach: (1) meas- 
urement of plasma levels of  fl-End and fl-LPH before and 
after exposure to stress and (2) measurement of  the release 
of B-End and B-LPH from anterior lobe pituitary cell prep- 
arations upon stimulation with ovine corticotropin releasing 
factor (oCRF). In addition, it is possible that sustained de- 
mand may cause some pools to be more or less releasable. 
Therefore, we compared the ratio of/3-End and B-LPH re- 
leased into plasma following exposure to 5 or 30 min foot- 
shock stress. 
M E T H O D  
Footshock Stress 
Sprague Dawley male rats (Charles River) are stressed 
with intermittent footshock as previously described [1,11]. 
The footshock stress session lasts either 5 or 30 minutes. 
Controls are naive, unhandled rats. 
Plasma Radioimmunoassays and Chromatography 
After decapitation, trunk blood is collected into tubes 
containing liquid NaEDTA on ice, and centrifuged to obtain 
plasma. The plasma is acidified with 1 N HCI to pH 3.0, and 
frozen immediately on dry ice and stored at -70°C until 
extraction. Plasma /3-End immunoreactivity (fl-End-IR) is 
assayed as described previously [4]. Briefly, peptides are 
extracted with Sep Pak C18 cartridges (Waters) using the 
manufacturer's recommended procedure for arginine vaso- 
pressin, fl-Endorphin immunoreactivity is assayed using a 
B-End radioimmunoassay (RIA) with an antibody (Brenda) 
to the midportion of fl-End 1-31. This antibody cross reacts 
equally well with B-LPH and fl-End. Using 12sI fl-End 1-31 
as a tracer, it shows only partial cross reactivity with 
N-acetylated and COOH-terminal shortened forms of  fl-End 
that is dependent upon the actual form. Thus, it shows 50% 
cross reactivity with NaAc fl-End 1-27, 80% cross reactivity 
with NAc fl-End 1-31 and 80% cross reactivity with fl-End 
1-27. ACTH is measured as previously described [11] using 
an antibody raised to ACTH 11-24. 125I ACTH 1-39 is used 
as a radiolabelled tracer. This antibody shows only partial 
(10%) reactivity with ACTH 18-39 (CLIP) and none with 
alpha-MSH (N-acetyl ACTH 1-13 amide). N-Acetyl 
B-endorphin is assayed using an N-terminus specific 
antibody that required acetylation for recognition by the 
antibody [1]. This antibody does not recognize non- 
acetylated B-endorphin. 125I N-acetyl B-endorphin 1-27 is 
used as a radiolabelled tracer. To separate fl-End and B-LPH 
sized material, molecular sieving with a G-50 Superfine, 1% 
formic acid column is used. For these experiments, the 
plasma from 10 animals, both stressed and unstressed are 
pooled, and applied to G-50 column for sieving (see [4] for 
more details). Individual fractions are dried down, resus- 
pended in assay buffer and individually quantitated. 
Pituitary Dispersed Cells Preparation 
For pituitary dispersed cell preparations, the glands are 
removed, and separated into anterior and neuro-intermediate 
lobe using a conservative dissection that avoids possible 
contamination of the anterior lobe with the POMC rich in- 
termediate lobe. Pituitaries are placed in oxygenated, 
calcium-free Krebs-Ringer bicarbonate buffer with 0.2% glu- 
cose and 0.5% bovine serum albumin (Fraction V, Sigma), 
0.2% sodium bicarbonate, 0.01% lima bean trypsin inhibitor, 
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FIG. 1. G-50 column sieving of plasma from control and stressed 
rats. Plasma from the stressed rats shows a greater increase in B-End 
than/3-LPH, suggesting that B-End is preferentially released during 
stress. The femtomoles released are calculated by subtracting con- 
trol "baseline" values from "acute stress" values. The control rats 
show predominantly fl-End-IR in plasma, which may be of IL origin. 
0.1% soybean trypsin inhibitor and 0.1% kanamycin 
(KRGBAIb). Pituitaries from all rats (n= 10/group) from the 
same group are pooled, and then treated with collagenase 
(Sigma, type 1) at 3 mg/ml in calcium free KRGBAlb for 60 
minutes at 37°C under 95% 02 + 5% CO2. Every 15 minutes 
the fragments are dispersed by repeatedly drawing them up 
and down into a plastic Pasteur pipette. The cells are then 
filtered through a 30 micron nylon mesh and washed three 
times with calcium free KRGBAlb by low speed centrifuga- 
tion (100xg). The cells are then resuspended in calcium con- 
taining KRGBAIb and incubated for 90 minutes to stabilize 
the cells. All incubations are carried out at 37°C under 95% 
02 + 5% CO2. Aliquots of  the cell preparations from each 
group, control and stress, are counted using a hemocytome- 
ter and the trypan blue dye exclusion method. Viability is 
greater than 95%. Following the stabilization period the cells 
are centrifuged and resuspended in fresh calcium containing 
KRGBAIb to a final concentration of  1 x l0 s cells/ml buffer 
for all cultures. Aliquots of cell suspensions (0.5 ml) are 
incubated with either medium only (unstimulated) or 
medium containing 1 nM synthetic oCRF (Bachem) for 60 
minutes. Both unstimulated and CRF stimulated release are 
set up in triplicate. Following the incubation period, the cells 
are centrifuged, and the medium saved and frozen at - 7 0  ° 
centigrade until extraction. The medium is extracted using 
the same Sep Pak C18 extraction procedure used for plasma 
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FIG. 2. Molar ratio of B-LPH to O-End in plasma after either 5 
minutes or 30 minutes of stress, and 10 minutes after the end of a 30 
minute footshock stress. The ratio of B-LPH to B-End released with 
stress remains relatively constant over this time frame. During the 
first 5 minutes of stress, the ratio of B-End to B-LPH released is 
1.7:1. The 10 minute post stress data shows that the rate of disap- 
pearance of B-LPH is slower than O-End, suggesting peripheral con- 
version of B-LPH to B-End is not the source of circulating B-End. 
B-End. At the end of the experiment, the AL cells are extract- 
ed by freezing and thawing in 5 N acetic acid with 0.2% 
bovine serum albumin. Total B-End plus B-LPH is measured 
using the same B-End RIA procedure as plasma. The extract- 
ed material is then sieved on a G-50 Superfine I% formic 
acid column to separate B-End from B-LPH as described 
above. The column fractions are assayed for O-End-IR. 
RESULTS 
Footshock stress releases several POMC derived pep- 
tides into plasma, as previously reported [6]. ACTH, a 
marker of anterior lobe release, increases 500% following 
footshock stress (30-+10 [SD] fmoles/ml to 166-+19 [SD] 
fmoles/ml). Likewise, fl-End-IR increases 500% following 
this same stressor (50-+ 14 [SD] fmoles/ml to 277-+ 16 [SD] 
fmoles/ml). In contrast, following footshock stress, 
N-acetyl-fl-End, a marker of intermediate lobe release, in- 
creases only 80% in plasma (30-+6 [SD] fmoles/ml to 52-+7 
[SD] fmoles/ml). Taken as a set, these data indicate that 
acute footshock stimulates release from the anterior lobe to a 
much greater extent than it stimulates release from the in- 
termediate lobe. Thus, the changes in B-End-IR seen follow- 
ing footshock appear to result from anterior lobe release into 
plasma of B-End and fl-LPH. 
To characterize the forms of B-End-IR in plasma, pooled 
plasma was applied to a G-50 column and the fractions were 
assayed for B-End-IR. The data from plasma sieving are seen 
in Fig. 1. Both B-End and B-LPH are present in rat plasma at 
rest and both are released with stress. Since the control 
"baseline" plasma sieving data may be influenced by 
B-End-IR of IL origin, to characterize the forms of B-End-IR 
released by stress, we subtracted control "baseline" values 
from the acute stress values before calculating the ratio• The 
ratio of B-End to B-LPH released by stress is approximately 
2:1. Since the anterior lobe from these animals contains 
mostly B-LPH(fl-LPH:B-End is 1.2:1 for the control group 
and 1.4:1 for the acute stress group), while the plasma shows 
mostly B-End, granules containing B-End, the most proc- 
essed form, appear to be preferentially released. An 
ACTH-RIA of these same G-50 column sieving fractions 
show femtomolar totals in close agreement with the total of 
B-LPH plus B-End, supporting the conclusion that the non- 
acetylated B-End is primarily of anterior lobe origin. (1) 
Further assurance that the IL is not responsible for the 
B-End size material released by stress is provided by the data 
that the intermediate lobe contributes primarily N or C ter- 
minally modified B-End [2,12], which shows only partial 
crossreactivity with our antibody under these conditions, 
and (2) even if the IL contributed to the B-endorphin-IR 
released with stress, C-terminally modified B-End is sepa- 
rated from authentic B-End on the sieving column and 
NAc-B-End was measured in these samples. If the NAc 
B-End-IR released with stress showed 100% cross reactivity 
with our antibody (which it does not), only 709 fmoles of 
N-acetyl B-End is present while 2380 fmoles of B-End size 
material was measured. The difference is 1671 fmoles of 
B-End size material compared to 869 fmoles B-LPH size 
material, yielding a ratio of B-End to B-LPH of 1.9:1. Thus, 
the evidence converges that the great majority of the B-End 
seen in plasma following stress is of anterior lobe origin. 
To examine the possibilities that either different pools 
may be released over time or that the peripheral conversion 
of B-LPH to B-End occurs during the course of our stress (30 
minutes), we examined a shorter stress, 5 minutes, and com- 
pared ratios of B-End size material to B-LPH at the end of 
the 30 minutes of stress and 10 minutes following the 30 
minute stress. The data in Fig. 2 shows that the ratio of 
B-End-size material to B-LPH size material released by 
stress remains constant across all stress conditions. During 
the first 5 minutes of stress, when the rate of release is far 
greater than the rate of degradation, the ratio of release of 
B-End to B-LPH is 1.7:1 suggesting that B-Endorphin is 
preferentially released even during the early stress period. If 
peripheral conversion of B-LPH to B-End were occurring, 
one would expect the ratio of B-End to B-LPH to increase 
ten minutes post stress as B-LPH was converted to 
fl-Endorphin. Using these data, we can actually calculate the 
rate of disappearance of B-LPH and B-End during this post 
stress period. While B-End-IR disappears at a rate of 13 
fmoles/min, B-LPH disappears at the rate of 5.5 fmoles/min, 
which does not suggest that B-LPH is being converted to 
B-End. In fact, it suggests that B-LPH may be more stable to 
breakdown in plasma than B-End. Thus, these ratios do not 
suggest that peripheral conversion of B-LPH to B-End is the 
source of the circulating B-End. 
Since the in viva plasma studies are complicated by the 
contribution of IL and the breakdown of both fl-LPH and 
B-End, we elected to study anterior pituitary release more 
directly, using anterior lobe dispersed cell preparations from 
either naive unhandled rats (control) or rats which had been 
stressed immediately prior to decapitation (acute stress). 
Previous studies within our laboratory [9] had indicated that 
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FIG. 3. G-50 column sieving of medium from control anterior lobe 
suspensions with and without CRF. The baseline (unstimulated) re- 
lease shows a 1:1 ratio of/3-End to /3-LPH. This contrasts with 
plasma data, where both anterior lobe and IL are contributing to 
pools of circulating/3-End-IR, making it difficult to determine the 
forms released by anterior lobe at rest. However, with CRF stimu- 
lation, the ratio of B-End to /3-LPH of released material is 2:1, 
suggesting the anterior lobe releases primarily/3-End. 
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FIG. 4. G-50 column sieving of medium from anterior lobe dis- 
sociated cells from rats which were stressed immediately before 
sacrifice. The unstimulated release is primarily B-End, in contrast to 
anterior lobe suspensions from control rats that show equal propor- 
tions of/3-End and/3-LPH released at rest. With CRF stimulation, 
the anterior lobe suspensions from both control and stressed rats 
demonstrate the predominance of/3-End release over/3-LPH release 
(/3-End:/3-LPH for control=2:l; /3-End:/3-LPH for acute 
stress=2.3:1). 
this same short term dispersed cell system showed differ- 
ences in the rate of biosynthesis and processing of POMC 
induced by stress and these same changes are still present 
several hours later. Therefore, the CRF and arginine vaso- 
pressin (AVP) released in vivo during the time of the stress 
may continue to influence the release of B-End and B-LPH in 
vitro. Consequently, we examined both baseline (unstimu- 
lated) and CRF stimulated release to determine the ratio of 
/3-End to B-LPH in both situations. The data are shown in 
Fig. 3 and 4. In preparations from control animals without 
CRF (Fig. 3), the baseline ratio of/3-End to/3-LPH released 
into the medium is 1:1. Addition of 1 nM CRF causes the 
total/3-End/B-LPH-IR to increase by 3 fold, but the ratio of 
B-End to B-LPH is now 1.6 to I. Since unstimulated release 
may represent a number of different physiological mech- 
anisms including cell death and may continue to occur even 
in the presence of CRF, we subtract baseline release from 
total release to obtain CRF stimulated release similar to the 
calculations used to determine forms released into plasma. 
After unstimulated release is subtracted from total release, 
then oCRF induced secretion of B-End:/3-LPH in a 2:1 ratio. 
This ratio is very close to the ratio of B-End to B-LPH in 
plasma after 30 minutes of footshock stress (B-End:B-LPH is 
1.9:1). In anterior lobe cell suspensions from stressed rats 
(Fig. 4), that is, rats already exposed to endogenous CRF 
and other endogenous secretagogues in vivo, the baseline 
release is predominantly B-End (2.8:1). Addition of CRF to 
the medium stimulates more release but induces little change 
in the ratio of/3-End to B-LPH released (2.4:1). If unstimu- 
lated release is subtracted from total release, the ratio of 
B-End to B-LPH is 2.3:1. It is unclear if this higher propor- 
tion of B-End release seen in anterior lobe suspensions fol- 
lowing acute stress represents a real difference from the 2:1 
ratio seen following CRF stimulation of anterior lobe sus- 
pensions from control rats. However, in all cases stimulated 
secretion is predominantly B-End. This occurs despite the 
fact that molecular sieving of the cells from these same sus- 
pensions show a B-End:/3-LPH ratio of 0.45:1 for control 
cultures and 0.4:1 for acute stress cultures. 
DISCUSSION 
In summary, both the in vivo stress studies and the in 
vitro CRF and stress studies indicate that/3-End is preferen- 
tially released over/3-LPH from the anterior lobe by approx- 
imately 2:1. The time course study shows that this pattern is 
not due to conversion of B-LPH to/3-endorphin, since the 
half-life of B-LPH in plasma appears to be longer than the 
half-life of B-End. The preferential release of B-End from the 
anterior lobe has a number of implications for our under- 
standing of the regulation of biosynthesis, processing, and 
release. While we have only examined a single stressor in 
vivo and a single releaser in vitro, and while we have not 
examined time points shorter than five minutes, the con- 
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vergence of the evidence within the current framework is 
rather striking. Our data suggest that/3-End is the preferred 
secreted end product derived from the processing of the 
carboxy-terminal domain of POMC. Together with the data 
of Allen et al. [3], the results indicate that the most mature 
ACTH granules may contain/3-End. Thus, although the ini- 
tial processing of POMC may stop at the conversion of 
POMC to ACTH and fl-LPH, processing may continue 
within some of the granules to form/3-End. These granules 
appear to form the most releasable pool. It also points out 
that what exists in the releasable pools may not match the 
molar ratios of peptides seen in the gland as a whole. Thus, 
while the usual ratio of/3-LPH to B-End in the anterior pitui- 
tary is 2:1, 2-fold more /3-End than /3-LPH is released by 
stress and CRF-- i .e . ,  four times more than predicted by the 
ratio of materials stored in the gland. 
The ability of anterior pituitary cells from stressed rats to 
continue to release 2-fold more/3-End than/3-LPH, even in 
the face of mild depletion to 80% control values (previously 
reported, [11]), suggests that the pool of/3-End can be re- 
plenished very quickly during the course of the stress and 
shortly thereafter. This is consistent with our previous find- 
ings [9] that post-translational processing is increased follow- 
ing acute stress, speeding the conversion of POMC to its 
final products. 
There exists an alternative explanation to the idea that 
different populations of releasable pools are related to the 
maturity of the granule. Our results can be equally well ex- 
plained by suggesting that/3-LPH is converted to/3-End in a 
release-coupled fashion. Such a phenomenon has been pro- 
posed in frog, where the authors have suggested that the last 
step in the post-translational modification of alpha-MSH is 
coupled to secretion [10]. While no such phenomenon has 
been demonstrated in mammals, our current work does not 
allow us to distinguish between the two alternative explana- 
tions. Similarly, it is possible that rather than subpopulations 
of releasable pools, there are subpopulations of secreting 
cells, and that the actively secreting cells produce primarily 
fl-End. 
Regardless of the mechanisms, the liberation of a larger 
than expected molar ratio of/3-End to/3-LPH points to the 
anterior lobe as an important source of circulating plasma 
/3-End. The dissociation between the ratio of B-End to 
fl-LPH in the anterior lobe versus the ratio of these peptides 
released from the anterior lobe into plasma suggests that 
simply measuring and sieving the whole anterior lobe does 
not provide the proper information to predict the forms re- 
leased. Therefore, in species such as man, in which/3-LPH is 
even more predominant in the anterior lobe than in rat [7], 
the anterior lobe may still release substantial/3-End in times 
of stress or with CRF stimulation. Consequently, the ratio of 
/3-End to /3-LPH must be evaluated in both unstimulated 
(basal) conditions and with stress or CRF infusion. 
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